|
Year Ended
|
||||||||
|
October 31,
2019
|
October 31,
2018
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income
|
$
|
40,491
|
$
|
61,236
|
||||
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
|
Depreciation and amortization
|
83,879
|
84,333
|
||||||
|
Share-based compensation
|
3,680
|
3,180
|
||||||
|
Changes in operating assets, liabilities and other
|
(56,210
|
)
|
(18,182
|
)
|
||||
|
Net cash provided by operating activities
|
71,840
|
130,567
|
||||||
|
Cash flows from investing activities:
|
||||||||
|
Purchases of property, plant and equipment
|
(177,191
|
)
|
(92,585
|
)
|
||||
|
Government incentives
|
22,364
|
1,005
|
||||||
|
Other
|
(33
|
)
|
711
|
|||||
|
Net cash used in investing activities
|
(154,860
|
)
|
(90,869
|
)
|
||||
|
Cash flows from financing activities:
|
||||||||
|
Proceeds from debt
|
54,633
|
-
|
||||||
|
Contribution from noncontrolling interest
|
29,394
|
17,996
|
||||||
|
Repayments of debt
|
(61,319
|
)
|
(4,639
|
)
|
||||
|
Dividends paid to noncontrolling interests
|
(45,050
|
)
|
(8,166
|
)
|
||||
|
Purchase of treasury stock
|
(21,696
|
)
|
(23,111
|
)
|
||||
|
Proceeds from share-based arrangements
|
2,071
|
4,634
|
||||||
|
Other
|
(92
|
)
|
(519
|
)
|
||||
|
Net cash used in financing activities
|
(42,059
|
)
|
(13,805
|
)
|
||||
|
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
|
2,381
|
(4,840
|
)
|
|||||
|
Net (decrease) increase in cash, cash equivalents, and restricted cash
|
(122,698
|
)
|
21,053
|
|||||
|
Cash, cash equivalents, and restricted cash, beginning of period
|
331,989
|
310,936
|
||||||
|
Cash, cash equivalents, and restricted cash, end of period
|
$
|
209,291
|
$
|
331,989
|
||||